DiffBind differential analyses of ERa ChIP-seq data performed in human breast cancer cell lines responsive or not to tamoxifen treatment (estrogen receptor inhibitor), from Ross-Innes et al. (Nature, 2012).
tamoxifenA DBA object (7 responsive patients and 4 resistant, 2795 sites)
Ross-Innes et al. (Nature, 2012) doi:10.1038/nature10730